Vimta Labs Limited has informed the Exchange that Record date for the purpose of Dividend is 30-May-2025.
VIMTALABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 2.5 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vimta Labs has fixed 30 May 2025 as the record date for a ₹2 per equity share dividend for FY25, subject to shareholder approval at the 35th AGM on 6 June 2025 (held via video conferencing). The AGM notice also seeks approval for a 1:1 bonus share issue (1 bonus share for every 1 held), an increase in the overall borrowing limit to ₹300 crores, and a strategic entry into the Biologics Contract Research and Development (CDMO) segment with an estimated ₹50 crore investment. Other agenda items include appointment of a secretarial auditor, re-appointment of an independent director, revision of remuneration for executive directors, and ratification of cost auditor fees. Dividend payment, if approved, is scheduled for 16 June 2025.
The combined ₹2 dividend and 1:1 bonus is shareholder-friendly, but the bonus will double the share count and proportionally halve per-share metrics like EPS and per-share dividend. The proposed Biologics CDMO foray signals long-term growth ambitions and could unlock new revenue, though it will raise capital requirements. Investors should track AGM voting outcomes and the post-bonus ex-date price adjustment.